Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.

MLA

Tham, Mylyne, et al. “Allosteric and Orthosteric Pharmacology of Cannabidiol and Cannabidiol-Dimethylheptyl at the Type 1 and Type 2 Cannabinoid Receptors.” British Journal of Pharmacology, vol. 176, no. 10, May 2019, pp. 1455–69. EBSCOhost, https://doi.org/10.1111/bph.14440.

APA

Tham, M., Yilmaz, O., Alaverdashvili, M., Kelly, M. E. M., Denovan-Wright, E. M., & Laprairie, R. B. (2019). Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. British Journal of Pharmacology, 176(10), 1455–1469. https://doi.org/10.1111/bph.14440

Chicago

Tham, Mylyne, Orhan Yilmaz, Mariam Alaverdashvili, Melanie E M Kelly, Eileen M Denovan-Wright, and Robert B Laprairie. 2019. “Allosteric and Orthosteric Pharmacology of Cannabidiol and Cannabidiol-Dimethylheptyl at the Type 1 and Type 2 Cannabinoid Receptors.” British Journal of Pharmacology 176 (10): 1455–69. doi:10.1111/bph.14440.